Metric Finance
LearnFAQ
LearnFAQ

Learn / INDV

NASDAQ: INDV

Indivior Pharmaceuticals (INDV) stock, explained like you're 5

Indivior Pharmaceuticals trades on the Nasdaq under the ticker INDV. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 4.2 billion dollars.

Ticker
INDV
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 4.2 billion dollars

Is Indivior Pharmaceuticals a small, medium or large cap company?

No. Indivior Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 4.2 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Indivior Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves INDV stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Indivior Pharmaceuticals, Inc. (INDV) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Why Did Indivior Pharmaceuticals (INDV) Stock Slide And What Is Behind It? (Simply Wall Street)
  • Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend (Indivior)
  • With 77.27% of shares represented, Indivior (INDV) stockholders vote on merger related share issuance. (Stock Titan)
  • Indivior Pharmaceuticals Inc (INDV) Stock Down 3.6% but Still Ov (GuruFocus)

Follow INDV in your daily brief

Each trading day at 5 PM ET we post what happened to Indivior Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow INDV

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Indivior Pharmaceuticals stock

What does Indivior Pharmaceuticals do?

Indivior Pharmaceuticals trades on the Nasdaq under the ticker INDV. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 4.2 billion dollars.

What is the ticker symbol for Indivior Pharmaceuticals?

Indivior Pharmaceuticals trades under the ticker INDV on the Nasdaq.

What is Indivior Pharmaceuticals's market cap?

Indivior Pharmaceuticals is a mid cap stock with a market cap of about 4.2 billion dollars.

How does Indivior Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves INDV stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow INDV stock every day?

Add INDV to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow INDV daily

A free brief on Indivior Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare INDV: INDV vs NVS, INDV vs AZN, INDV vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed